NUZ vs PCK

ASX Healthcare sector comparison — updated 23 Jul 2026 — Healthcare sector

NUZ

NEURITHERA FPO [NUZ]

50MEDIUM

PCK

PAINCHEK FPO [PCK]

50MEDIUM

Score Breakdown

NUZ PCK
Technical
39
55
Catalyst
51
51
Sentiment
50
50
Fundamental
48
51
Momentum
36
28
Risk Gate
50
39

Key Metrics

NUZ Metric PCK
$48.8MMarket Cap$21.9M
1.0MAvg Volume (20d)129K
N/AShort InterestN/A
$0.18552-Week High$1.050
$0.05552-Week Low$0.095
-1.6%Daily Change+5.0%
$0.063Reference Price$0.105
-147.1%ROE-383.2%
-248.4%Profit Margin-268.1%

Active Signals

NUZ Signals

●MACD momentum is losing steam
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.8 quarters)
●Moderate P/S ratio (8.2x)
●Strong revenue growth (+290%)
●Near 52-week low (6% of range)
●Small-cap ($20-100M)
●Deeply negative margins (-248%)

PCK Signals

●MACD momentum is picking up steam
●Stochastic is deep in oversold territory — bounce conditions forming
●Trading below both moving averages — the trend is working against this one
●Drifting lower — down 8.7% over the last 5 days
●Beating the Small Ords index — relative strength of 1.14, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Low cash runway (3 quarters) - dilution risk
●Moderate P/S ratio (6.4x)

Ask Scout AI to compare NUZ and PCK in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

PCK vs SLD →ACW vs SPL →ACW vs NSB →ACW vs HIQ →NSB vs SPL →
NUZ Full Analysis → PCK Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).